Unveiling the Potential of HIMS: A Super Gem in the Stock Market

PUBLISHED Jan 7, 2025, 4:32:12 AM        SHARE

img
imgBeat the Denominator on YouTube

Unveiling the Potential of HIMS: A Super Gem in the Stock Market

https://youtu.be/wRMzGpTLwdM?si=F5fK3MiqUDnKViTH

I still find this stock dirt cheap, especially now that we trended back towards 25 bucks. This is a stock that peaked at around 34, and I find it just as compelling as in 2024. I think we're going to have a wonderful 2025. This is my first coverage of HIMS for 2025, so let's dive in!

Financial Overview

HIMS is one of those companies I discovered because it was always cheap on my tracker. It still comes up cheap in my tracker. On my Patreon, I share this extensive spreadsheet with all of these stocks, categorized as "super gems." A super gem for me must:

  • Exceed a rule of 40.
  • Be inexpensive on Enterprise Value over gross profit over Revenue growth.
  • Show outstanding growth (preferably over 30%).
  • Have outstanding gross margin profitability.

If you look at the top four stocks, three of them are healthcare stocks, and HIMS is one of the cheapest, trading at 0.1 and achieving a rule of 40 of 66.

Super Gem Status

HIMS stands out as my first third super gem and my second super gem if we exclude Giga Cloud, which many do because of its operations in China. HIMS is really the second cheapest after LifeMD. I also own LifeMD, but HIMS is my biggest position among LifeMD, HIMS, and TransMedics.

Market Disruption

Healthcare disruption is coming, and healthcare stocks like HIMS are very cheap and ignored by the market. Analysts are missing the zero-to-one disruptions happening in the healthcare sector, and HIMS is incredibly disruptive.

Financial Growth and Stability

HIMS is predicted to grow revenues at 53% over the next 12 montHIMS, with a 79% gross margin and a 13% EBITDA margin. You might think revenue growth will slow down, but for HIMS, revenue is actually accelerating.

The stock is trading at 2.56 times forward revenue, making it very cheap on a price-to-revenue and price-to-sales basis. HIMS has an enterprise value roughly the same as its market cap because it carries little to no debt.

Subscription Business Model

HIMS operates on a subscription business model, which is a favorite among investors. Once a sale is made, it becomes recurring revenue. Most of HIMS's revenue is from perpetual treatments, ensuring steady income.

HIMS has 2 million customers, which significantly reduces concentration risk compared to other healthcare companies. This diverse customer base means the company is less affected by policy changes from major customers like Medicare.

Recession-Proof Product

HIMS deals with deeply personal health issues such as ED, hair loss, weight loss, anxiety, and mental health. These issues are recession-proof because people are likely to continue paying for treatments that significantly impact their quality of life.

Competition and Market Position

HIMS's main competition comes from retail pharmacies like Walgreens and CVS, which are struggling. As these competitors close stores, HIMS's market position strengthens. HIMS provides the best product at the lowest cost, following a zero-to-one strategy similar to companies like Gmail, YouTube, and Spotify.

Why HIMS is the Best and Most Affordable Healthcare Solution

Unmatched Affordability

For just $7.99 to $88.99 a month, HIMS provides access to 100 million songs, which is six orders of magnitude cheaper than buying a CD back in 1995. This affordability extends to their healthcare solutions, making it accessible to a broader audience.

Personalized Medication

One of the standout features of HIMS is its ability to offer compounded medications. Approximately half of the users benefit from custom options and treatments. This is made possible through large, highly automated warehouse pharmacies equipped with an AI recommender system. This system calculates the exact milligrams of each active ingredient needed based on the user's weight and specific needs.

The AI Recommender System

The AI recommender system is a game-changer. It ensures that each pill contains the precise amount of medication required. For instance, if a user needs 7.5 milligrams of a particular ingredient, the system can provide that exact dosage, eliminating the need for users to cut pills in half or take incorrect dosages.

Customer-Centric Approach

HIMS's business model is centered around the customer. The company prioritizes the user's convenience and health by offering compounded medications that are personalized. This customer-centric approach is evident on their website, where they emphasize personalized treatments for various health issues, including mental health, sexual health, and skincare.

Example: ED and Heart Health Combo

A prime example of HIMS's personalized approach is their ED and heart health combo pill. This red pill is customized to include the exact amount of tadalafil or sildenafil needed, along with atorvastatin for heart health. This combination ensures that users get the precise treatment they need in a single pill, enhancing their overall well-being.

Simplifying Medication for the Elderly

The elderly often face the challenge of managing multiple medications. HIMS addresses this issue by combining multiple treatments into a single pill. This not only simplifies their medication regimen but also increases the likelihood of adherence, improving their health outcomes.

Cost-Effectiveness Without Insurance

HIMS's model is particularly beneficial for those without insurance or with high-deductible health plans. Traditional healthcare often involves multiple doctor visits and follow-ups, leading to high out-of-pocket expenses. HIMS eliminates these costs by bundling unlimited visits and follow-ups with the cost of medication, making it a more affordable option.

Conclusion

HIMS is revolutionizing the healthcare industry with its affordable, personalized, and customer-centric approach to medication. By leveraging advanced AI technology and a commitment to user convenience, HIMS offers a superior alternative to traditional healthcare models. Whether you have insurance or not, HIMS provides a cost-effective solution that ensures you get the precise treatment you need, enhancing your overall health and well-being.

https://youtu.be/wRMzGpTLwdM?si=F5fK3MiqUDnKViTH



Sound investments
don't happen alone

Find your crew, build teams, compete in VS MODE, and identify investment trends in our evergrowing investment ecosystem. You aren't on an island anymore, and our community is here to help you make informed decisions in a complex world.

More Reads
Unveiling Coca-Cola: The Ninth Best-Performing Stock and Its Future Prospects
Image

The best-performing Consumer Staples stock ever returned 12 million percent. That means a dollar invested would have turned into $123,000. It's the ninth best-performing stock ever. You're dying to know which stock it is, aren't you?

Investing in Micron: Timing the Cyclical Nature of the AI Boom
Image

Micron Technology stands to benefit significantly from the AI boom. The first key question to consider is whether the business has improved, and the answer is a resounding yes. For Q1 2025, Micron's revenue nearly doubled from $4.7 billion in Q1 2024 to $8.7 billion. Additionally, the company swung from a net loss of $1 billion last year to a net profit of $2 billion this quarter.

Analyzing Sofi Technologies' Business Growth and Future Prospects
Image

To gauge whether Sofi Technologies is a worthy investment at its current market capitalization of approximately $16 billion, one must analyze several key business indicators. This company shows promising growth potential, with the possibility of increasing its market cap to $50 billion.

Buffett's Investment in Sirius XM
Image

One of the latest additions to Warren Buffett's portfolio is Sirius XM (ticker symbol SIRI). Recently, Buffett increased his stake in the company by 12 million shares, bringing the total investment to over $2.8 billion, which now constitutes just over 1% of his overall portfolio. This move has generated a lot of buzz in the financial community.

Verisign: An In-Depth Look at Buffett's Investment and Its Growth Potential
Image

another stock that has captured Warren Buffett's attention is Verisign (ticker symbol VRSN). Buffett recently purchased another 234,000 shares, bringing his total investment in Verisign to over $2.5 billion, which constitutes just under 1% of his portfolio. This is a stock I personally own and highly regard.

Domino's Stock Analysis: Warren Buffett's Investment and Growth Potential
Image

Coming in at purchase number two is the renowned pizza giant, Domino's (SEC symbol DPZ). Recently, Warren Buffett purchased almost $550 million worth of Domino's stock last quarter, attracting significant attention in the financial world.

The Significance of TSM: An In-Depth Analysis of Its Performance and Role in the Tech Industry
Image

In recent years, TSM (Taiwan Semiconductor Manufacturing Company) has been a hot topic, and it's clear why. The company's stock has soared by an impressive 247% over the last five years, far outpacing the S&P 500's 90% increase during the same period. Even on a shorter scale, TSM's one-year performance has surged by 105%, highlighting its robust growth.

The AI Boom in Tech Stocks: Winners and Losers
Image

AI is revolutionizing industries, driving innovation, and transforming the stock market. This article explores the history, advancements, and benefits of AI, from generative models like ChatGPT to applications in sectors such as healthcare, finance, and transportation. In 2024, the stock market showcased clear winners like Nvidia, Microsoft, and Tesla, which capitalized on AI technologies, and losers like Intel and Snapchat, which struggled to adapt. While AI offers opportunities for efficiency, automation, and economic growth, it also brings challenges, including overvaluation fears, ethical dilemmas, and regulatory scrutiny. Looking forward, companies that balance innovation with responsible practices will define AI's sustainable impact.

Is Vertiv a BUY Even After a Massive Run?
Image

An in depth look at Vertiv (VRT)

Not a Cheap Market
Image

Stock Market Commentary

The Evolution of Holiday Shopping: Winners, Trends, and Economic Insights for 2024
Image

The 2024 holiday shopping season showcases resilience as retailers adapt to inflation's impact on consumer spending. With extended discounts and hybrid shopping models, companies like Amazon, Walmart, and Target attract value-focused buyers. This article further explores economic conditions, retail strategies (E-commerse vs brick and mortar), key players and popular gifts.

USLM Stock Soars 209% YTD: Why United States Lime & Minerals Is a Strong Buy
Image

United States Lime & Minerals (USLM) has emerged as a top-performing stock in 2024, delivering an impressive 209% YTD return. Operating in the cyclical materials industry, USLM benefits from favorable macroeconomic conditions, including lower inflation and increasing infrastructure demand. This article takes a closer look into the fundamentals and financial ratios to determine whether USLM is an attractive buying opportunity for investors.

Is Target Stock Undervalued? A Comprehensive Analysis of TGT in 2024?
Image

Target (TGT), a cornerstone of the U.S. retail industry, has faced a mix of opportunities and challenges in recent years. This article analyzes Target's financial performance, key metrics, and competitive positioning, highlighting its resilience in navigating economic pressures like inflation and shifting consumer behaviors towards digital shopping. Despite margin compression in 2023, Target has showcased recovery in 2024, driven by its focus on e-commerce, operational efficiency, and innovative shopping solutions. With steady dividend payouts and potential undervaluation, Target presents an opportunity for long-term investors.

2024 Bitcoin Price Insights: Trends and Predictions for 2025
Image

Bitcoin experienced significant price growth in 2024, surging from $40,000 in January to an all-time high of $99,000 in November. Key factors driving this growth included the Bitcoin halving event, increased institutional investment, and the pro-crypto stance of President Trump’s administration following the U.S. elections. The introduction of spot Bitcoin ETFs and options trading further fueled market demand.

Vale Commits to Restoring Hectares of the Amazon Rainforest
Image

Vale’s commitment to sustainability, including its pledge to restore 500,000 hectares of degraded land in the Amazon rainforest by 2030, positions it favorably in an increasingly environmentally conscious market.

Why You Should Take a look at Boise Superior Industries International
Image

Superior Industries International, Inc. (NYSE:SUP) is a leading global supplier of aluminum wheels. The company designs, engineers, and manufactures a wide variety of innovative and high-quality products using the latest lightweighting and finishing technologies.

Boise Cascade is a leading manufacturer and distributor of building materials
Image

Boise Cascade has a strategic approach to growth through acquisitions. In 2022, the company acquired Coastal Plywood Company, significantly expanding its manufacturing capacity and product offerings.

Freeport-McMoRan - The Top Miner of Gold, Silver, and Molybdenum
Image

Freeport-McMoRan is a leading mining company with a diverse portfolio of mineral assets. It primarily explores for copper, gold, molybdenum, silver, and other metals.

Is Costco Stock Worth Buying?
Image

Costco is one of the world's largest wholesale companies. Does that make it a worthy buy opportunity?

Resources for Publishers
Resources for New Investors
Boosted with BossCoin
Financial Literacy Leaders
user_profile
Wise Intelligent
user_profile
Tom Hamilton
user_profile
Mark Robertson
user_profile
Kevin Matthews II
user_profile
Akeiva Ellis
user_profile
Brendan Dale
user_profile
Kenneth Chavis IV
user_profile
Sharita Humphrey